Bordado, Letecia D.

HRN: 29-46-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2026
CIPROFLOXACIN 2MG/ML, 100ML IV
08/10/2026
08/17/2026
IV
200mg
Q12h
DM FOOT
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines